Update in Internal Medicine
April 24–26, 2014
|General Information||Instructional Team|
Primary care providers and specialists in Internal Medicine and Family Practice seeking updates in practical knowledge relating to patient care.
Overview and Purpose
The Update in Internal Medicine is a program emphasizing topics requested by our referring physicians, controversies arising from journal clubs, and posed by our trainees. The program highlights diagnostic and therapeutic solutions based on the most recent clinical science. The goal is to provide state-of-the art practical advice on issues identified as frequent items for consultation and second opinions, as well as new advances in applying molecular techniques in translational medicine.
Continuing Education Information
This live activity has been approved for 19.25 AMA PRA Category 1 Credits™.
- Utilize routine testing of electrolytes to understand subclinical acid-base disturbances
- Review primary-care aspects of chronic kidney disease
- Integrate new guidelines for management of rheumatoid arthritis
- Utilize the current ACCP guidelines for management and diagnosis of pulmonary embolism
- Discuss the ethical principles of end-of-live care
- Utilize evidence-based guidelines for lipid management
- Translate into direct patient care the basis of treating low testosterone states
- Implement current strategies for hypercoagulable workups
UT Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Conflict of Interest
It is UT Southwestern’s policy that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed in the course syllabus.
Discussion of Off-Label Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be “off-label” use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.